comparemela.com

Latest Breaking News On - Yonsei cancer center - Page 1 : comparemela.com

Dr Cho on Amivantamab Plus Lazertinib in Atypical EGFR-Mutated NSCLC

Byoung Chol Cho, MD, PhD, discusses findings from the CHRYSALIS-2 trial of amivantamab plus lazertinib in patients with atypical EGFR-mutant NSCLC.

Rybrevant Plus Leclaza Has Very Potent Activity in Lung Cancer Subset

Rybrevant plus Leclaza had promising response and progression-free survival rates in patients with EGFR-mutant non-small cell lung cancer.

Patients on edge as doctors prepare for hospitals walkout

Medical institutions were in a frantic dash Monday morning as junior doctors at Seoul’s “Big Five” hospitals moved to tender their resignation letters en masse Monday and walk out of their jobs on Tuesday at 6 a.m. in protest against the government’s planned hike in medical school enrollment quota. With a face full of worry, a woman in her 60s grabbed onto medical personnel at the main lobby o.

Patients on edge as doctors prepare for hospital walkout

Medical institutions were in a frantic dash Monday morning as junior doctors at Seoul’s “Big Five” hospitals moved to tender their resignation letters en masse Monday and walk out of their jobs on Tuesday at 6 a.m. in protest against the government’s planned hike in medical school enrollment quota. With a face full of worry, a woman in her 60s grabbed onto medical personnel at the main lobby o.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.